Robuta

https://www.biospace.com/xbiotech-usa-enrolls-first-patient-under-revised-protocol-for-u-s-phase-iii-registration-study-using-xilonix-for-treatment-of-metastatic-colorectal-c
for uxbiotechusafirstpatient
https://www.news-medical.net/news/20110708/Top-line-results-from-HyQ-subcutaneous-IG-phase-III-study-in-patients-with-primary-immunodeficiency.aspx
Baxter International Inc. and Halozyme Therapeutics, Inc. today announced top-line results of a phase III study of HyQ, an investigational facilitated...
phase iii studytop lineresultssubcutaneousig
https://www.biospace.com/genentech-shows-off-positive-phase-iii-lymphoma-data-from-late-stage-study
shows offphase iiigenentechpositivelymphoma
https://www.biospace.com/genentech-south-sf-phase-iii-study-showed-two-years-of-actemra-r-tocilizumab-inhibited-progression-of-joint-damage-and-improved-disease-remissio
phase iii studysouth sftwo yearsgenentechshowed
https://www.news-medical.net/news/20110412/Baxters-ARTISS-phase-III-study-results-in-face-lift-surgery-presented-at-AAPS-meeting.aspx
Baxter International Inc. announced today the results of a phase III study evaluating the safety and efficacy of ARTISS in 75 patients.
phase iii studyin facebaxterartissresults